文献速递血液透析通路

种族与民族与血管通路类型选择及结局的关联

Association of Race and Ethnicity with Vascular Access Type Selection and Outcomes.
PubMed 文献 · Ann Vasc Surg · 2019-08-30

该研究基于Optum理赔数据库2011-2017年数据,纳入7584例经隧道式血透导管启动透析的慢性肾病患者,分析种族与动静脉内瘘(AVF)对比动静脉移植物(AVG)选择及通路结局的关联。结果显示黑人患者选择AVF的 odds 比白人低36%,且需要二次通路的 odds 高58%,二次通路建立时间更短,提示黑人患者通路失败更早更频繁。

要点

  • 黑人患者初始选择AVF而非AVG的 odds 比白人低36%(P<0.001)。
  • 黑人患者需要第二次通路建立的 odds 比白人高58%(P<0.001),且时间更短。
  • 移植物患者较瘘管患者血栓清除时间更短(总体高73%),但西班牙裔移植物患者更明显。

核心结论

  • 黑人患者与白人相比,初始通路成功时间无差异,但通路失败更早且更频繁,独立于通路类型、年龄和合并症。

研究设计与样本

  • 回顾性队列研究,使用Optum去标识化Clinformatics Data Mart理赔数据库(2011-2017),纳入7584例经隧道式血透导管启动透析的慢性肾病患者,其中AVF 5852例(77%),AVG 1732例(23%)。

主要发现

  • 黑人患者初始选择AVF而非AVG的 odds 比白人低36%(P<0.001)。
  • 70岁及以上和糖尿病患者初始AVF的 odds 更低,男性和肥胖患者更高。
  • 移植物患者较瘘管患者血栓清除时间更短的可能性高73%,西班牙裔移植物患者较白人高25%。
  • 随访期间1589例(21%)患者接受二次通路建立:白人19%(n=802),黑人26%(n=483),西班牙裔19%(n=250),亚裔19%(n=54)(P<0.001)。
  • 多因素分析显示黑人患者需要第二次通路的 odds 比白人高58%(P<0.001),且第二次通路建立时间更短的可能性高45%。

临床怎么用

  • 临床应关注黑人血透患者通路失败风险较高的问题,加强通路监测和二次通路规划。
  • 对于糖尿病患者和70岁以上患者,初始AVF选择需个体化评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Black patients with end-stage renal disease (ESRD) represent 30.5% of the prevalent ESRD population in the United States, despite only accounting for 18% of the total population. Black patients are less likely to have pre-ESRD care compared with their white counterparts and are 3-4 times more likely to progress from chronic kidney disease to ESRD than whites, suggesting that black patients are particularly vulnerable to disparities in outcomes related to hemodialysis and ESRD. The objective of this study is to examine the association of race with outcomes of hemodialysis access and selection of arteriovenous fistula (AVF) versus arteriovenous graft (AVG). METHODS: Patients with chronic kidney disease who initiated dialysis through a tunneled hemodialysis catheter (THC) were identified in the Optum's De-identified Clinformatics® Data Mart (OptumInsight, Eden Prairie, MN) claims database (2011-2017). The odds of AVF versus AVG creation and the odds of repeat vascular access creation were analyzed using logistic regression. Time from initial AVF/AVG to THC removal and time to repeat AVF/AVG were analyzed using Cox proportional hazards. RESULTS: About 7,584 vascular access patients met the inclusion criteria: 5,852 (77%) AVF and 1,732 (23%) AVG. Median follow-up was 583 days overall (range, 1-2,543), 589 days among AVF patients (range, 1-2,543), and 260 days among AVG patients (range, 1-2,529). Between races, there was no clinically significant variation in characteristics or comorbidities, with the exception of a much lower rate of obesity among Asians. Black patients had 36% lower odds of AVF index versus AVG index (P < 0.001). Patients 70 years or older and patients with diabetes had lower odds of AVF index, whereas men and obese patients had greater odds of receiving AVF. Overall, graft patients were 73% more likely to have a shorter time to THC removal than fistula patients, but Hispanic graft patients were 25% more likely to have a shorter time to THC removal than whites. Patients with diabetes, patients with cardiac arrhythmia, and obesity were more likely to have a longer time to THC removal. About 1,589 (21%) patients underwent a repeat vascular access creation during the follow-up period: 19% of whites (n = 802), 26% of blacks (n = 483), 19% of Hispanics (n = 250), and 19% of Asians (n = 54) (P < 0.001). Multivariate analysis demonstrated that black patients had 58% greater odds of requiring a second access than white patients (P < 0.001). Graft patients, patients 70 years or older, and men had lower odds of repeat access. Black patients were 45% more likely to have a shorter time until second access creation. Graft patients, patients aged 70 years or older, and men were more likely to have a longer time until second access. Patients with obesity were more likely to have a shorter time until second access. CONCLUSIONS: This study's findings suggest that after initial vascular access, compared with whites, blacks have no difference in time to index access success, but their access fails earlier and more frequently, independent of access type, age, and comorbidities. Given blacks constitute 30.5% of the hemodialysis population in the United States, it is imperative that future research investigate the root causes of these disparities.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Copeland TP, Hye RJ, Lawrence PF, et al. Association of Race and Ethnicity with Vascular Access Type Selection and Outcomes. Ann Vasc Surg. 2019. PMID: 31476426. doi:10.1016/j.avsg.2019.08.068

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。